Related references
Note: Only part of the references are listed.Dissecting the Specificity of Adenosyl Sulfamate Inhibitors Targeting the Ubiquitin-Activating Enzyme
Mohit Misra et al.
STRUCTURE (2017)
Drugging the undruggables: exploring the ubiquitin system for drug development
Xiaodong Huang et al.
CELL RESEARCH (2016)
The increasing complexity of the ubiquitin code
Richard Yau et al.
NATURE CELL BIOLOGY (2016)
Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis
Daniel J. Anderson et al.
CANCER CELL (2015)
NEDD8 Inhibition Overcomes CKS1B-Induced Drug Resistance by Upregulation of p21 in Multiple Myeloma
Junwei Huang et al.
CLINICAL CANCER RESEARCH (2015)
Lenalidomide induces ubiquitination and degradation of CK1a in del(5q) MDS
Jan Kroenke et al.
NATURE (2015)
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Luke A. Gilbert et al.
CELL (2014)
Cleaning up in the endoplasmic reticulum: ubiquitin in charge
John C. Christianson et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
Pharmacogenomic Approach to Identify Drug Sensitivity in Small-Cell Lung Cancer
Gary Wildey et al.
PLOS ONE (2014)
Genetic Screens in Human Cells Using the CRISPR-Cas9 System
Tim Wang et al.
SCIENCE (2014)
MLN2238, a proteasome inhibitor, induces caspase-dependent cell death, cell cycle arrest, and potentiates the cytotoxic activity of chemotherapy agents in rituximab-chemotherapy-sensitive or rituximab-chemotherapy-resistant B-cell lymphoma preclinical models
Juan J. Gu et al.
ANTI-CANCER DRUGS (2013)
BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma
J. S. Wilmott et al.
BRITISH JOURNAL OF CANCER (2013)
The Ubiquitin Code
David Komander et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 81 (2012)
Treatment-Emergent Mutations in NAEβ Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924
Michael A. Milhollen et al.
CANCER CELL (2012)
Ubiquitin-activating enzyme UBA1 is required for cellular response to DNA damage
Pavel Moudry et al.
CELL CYCLE (2012)
Mechanistic Studies on Activation of Ubiquitin and Di-ubiquitin-like Protein, FAT10, by Ubiquitin-like Modifier Activating Enzyme 6, Uba6
James M. Gavin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Ubiquitin and SUMO in DNA repair at a glance
Helle D. Ulrich
JOURNAL OF CELL SCIENCE (2012)
Discovery of a Potent and Orally Bioavailable Benzolactam-Derived Inhibitor of Polo-Like Kinase 1 (MLN0905)
Matthew O. Duffey et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Identification and Mechanistic Studies of a Novel Ubiquitin E1 Inhibitor
Dana Ungermannova et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
Inhibition of NEDD8-Activating Enzyme Induces Rereplication and Apoptosis in Human Tumor Cells Consistent with Deregulating CDT1 Turnover
Michael A. Milhollen et al.
CANCER RESEARCH (2011)
Mechanistic Studies of Substrate-assisted Inhibition of Ubiquitin-activating Enzyme by Adenosine Sulfamate Analogues
Jesse J. Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets
Lynn Bedford et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma
G. Wei Xu et al.
BLOOD (2010)
Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In Situ
James E. Brownell et al.
MOLECULAR CELL (2010)
The ubiquitin-proteasome system in cancer, a major player in DNA repair. Part 2: transcriptional regulation
Panagiotis J. Vlachostergios et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Teresa A. Soucy et al.
NATURE (2009)
E1 Ubiquitin-Activating Enzyme UBA-1 Plays Multiple Roles throughout C. elegans Development
Madhura Kulkarni et al.
PLOS GENETICS (2008)
E1 Ubiquitin-Activating Enzyme UBA-1 Plays Multiple Roles throughout C-elegans Development
Madhura Kulkarni et al.
PLOS GENETICS (2008)
Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics
Yili Yang et al.
CANCER RESEARCH (2007)
Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging
Jianping Jin et al.
NATURE (2007)
Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase
Mark G. Manfredi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The integration of macromolecular diffraction data
AGW Leslie
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2006)
Scaling and assessment of data quality
P Evans
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2006)
The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle
A Hershko
CELL DEATH AND DIFFERENTIATION (2005)
The comet assay for DNA damage and repair - Principles, applications, and limitations
AR Collins
MOLECULAR BIOTECHNOLOGY (2004)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
A graphical user interface to the CCP4 program suite
E Potterton et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2003)
A phase 2 study of bortezomib in relapsed, refractory myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
